Phase 1 Study of Anti-PD-L1 Monoclonal Antibody KN035 to Treat Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT02827968 · COMPLETED
Trial details
- NCT number
- NCT02827968
- Sponsor
- 3D Medicines (Sichuan) Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-13
- Primary completion
- 2020-08-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.